z-logo
open-access-imgOpen Access
Molecular Profiling and Research of Therapeutic Targets
Author(s) -
Sumera Rizvi,
Gregory J. Gores
Publication year - 2015
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000375347
Subject(s) - medicine , telomerase , targeted therapy , hepatocellular carcinoma , wnt signaling pathway , telomerase reverse transcriptase , carcinogenesis , cancer research , bioinformatics , oncology , cancer , genetics , gene , biology
The heterogeneous nature of hepatocellular carcinoma (HCC) poses a challenge to effective therapy. Significant strides have been made in molecular profiling. Telomerase promoter mutations are now known to represent early events in linear carcinogenesis. However, the translation of these advances into clinical practice has been limited. Although further work is needed to extrapolate genetic information to patient care, progress has been made in using genetics and stratification for HCC therapy. Targeted therapies for patients with c-MET overexpression, VEGF-A amplification and Wnt β-catenin-driven tumors offer promise.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom